Zum Hauptinhalt springen

Aktuelle Publikationen

Monya Baker, Editor, Nature Reports Stem Cells

„Data supplied by both users and companies can be sparse, and some projects share data only if they confirm that an antibody works as expected. “Sometimes it seems easier to hire a detective than to order a specific antibody,” concludes an overview of antibody portals“

 

 

 

Eine erfreuliche Nachricht:

Katja Hanack und Diana Pauly wurden mit ihrem 2015 erschienenen Artikel "How to avoid pitfalls in antibody use" von Monya Baker in ihrem Artikel "Antibodies used in research often give murky results. Broader awareness and advanced technologies promise clarity" bei nature zitiert.


Publikationen 2022

Hirschberg, S., Bauer H., Kamhieh-Milz, J., Ringel, F., Harms, C., Eddin, OK., Pruß, A., Hanack, K., Schulze-Forster, K. (2022).

SARS-CoV-2 Virus-like Particles (VLPs) Specifically Detect Humoral Immune Reactions in an ELISA-Based Platform.

Antibodies 2022, 11, 76. doi.org/10.3390/antib11040076

link

Schlör, A., Hirschberg, S., Amor, GB., Meister, TL., Arora, P., Pöhlmann, S., Hoffmann, M., Pfaender, S., Eddin, OK., Kamhieh-Milz, J., Hanack, K. (2022).

SARS-CoV-2 neutralizing camelid heavy-chain-only antibodies as powerful tools for diagnostic and therapeutic applications.

Front Immunol. 2022 Sep 14;13:930975. doi: 10.3389/fimmu.2022.930975.

link

Gätjen, D., Wieczorek, M., Listek, M., Tomszak, F., Nölle, V., Hanack, K., Droste, M. (2022).

A switchable secrete-and-capture system enables efficient selection of Pichia pastoris clones producing high yields of Fab fragments.

Journal of Immunological Methods. doi.org/10.1016/j.jim.2022.113383.

link

Michelchen, S., Micheel, B., Hanack, K. (2022).

Antigenspezifische Aktivierung von B-Lymphozyten in vitro.

BIOspektrum. DOI: 10.1007/s12268-022-1829-z.

link

Chaudhari, A., Joshi, M., Kumar, D., Patel, A., Lokhande, K.,B., Krishnan, A., Hanack, K., Filipek, S., Liepmann, D., Renugopalakrishnan, V., Paulmurugan, R., Joshi, C. (2022).

Evaluation of Immune Evasion in SARS-CoV-2 Delta and Omicron variants.

Computational and Structural Biotechnology Journal. doi.org/10.1016/j.csbj.2022.08.010.

link

Engel, R., Micheel, B., Hanack, K. (2022).

Three-dimensional cell culture approach for in vitro immunization and the production of monoclonal antibodies.

Biomedical Materials 2022 Jun 21. doi: 10.1088/1748-605X/ac7b00.

link

Czarnecka, M., Weichelt, U., Rödiger, S., Hanack, K. (2022).

Novel Anti Double-Stranded Nucleic Acids Full-Length Recombinant Camelid Heavy-Chain Antibody for the Detection of miRNA.

Int. J. Mol. Sci. 2022, 23(11), 6275; doi.org/10.3390/ijms23116275.

link


Publikationen 2021

Fudickar, W., Roder, P., Listek, M., Hanack, K., Linker T. (2021).

Pyridinium Alkynylanthracenes as Sensitizers for Photodynamic Therapy.

Photochem Photobiol  2021 Oct 31. doi: 10.1111/php.13554.

link

Göthel, M., Listek, M., Messerschmidt, K., Schlör, A., Hönow, A., Hanack, K. (2021).

A New Workflow to Generate Monoclonal Antibodies against Microorganisms.

Appl. Sci. 2021, 11(20), 9359; doi.org/10.3390/app11209359

link

Michelchen, S., Micheel, B., Hanack, K. (2021).

In vitro immunization approach to generate specific murine monoclonal IgG antibodies.

J. Immunol. Methods; Volume 499, December 2021, 113149;  doi.org/10.1016/j.jim.2021.113149

link


Publikationen 2020

Listek, M., Hönow, A.,  Gossen, M., Hanack, K. (2020).

A novel selection strategy for antibody producing hybridoma cells based on a new transgenic fusion cell line.

Sci Rep10, 1664 (2020). doi.org/10.1038/s41598-020-58571-w

link


Publikationen 2019

Lütkecosmann, S., Faupel, T., Porstmann, S., Porstmann, T., Micheel, B., Hanack, K. (2019).

A cross-reactive monoclonal antibody as universal detection antibody in autoantibody diagnostic assays.

Clin Chim Acta. 2019 Sep 4;499:87-92. doi: 10.1016/j.cca.2019.09.003.

link


Publikationen 2018

Schlör, A., Holzlöhner, P., Listek, M., Grieß, C., Butze, M., Micheel, B., Hentschel, C., Sowa, M., Roggenbuck, D., Schierack, P., Füner, J., Schliebs, E., Goihl, A., Reinhold, D., Hanack, K. (2018).

Generation and validation of murine monoclonal and camelid recombinant single domain antibodies specific for human pancreatic glycoprotein 2.

N Biotechnol. 2018 Apr 7. pii: S1871-6784(17)30269-8. doi: 10.1016/j.nbt.2018.03.006.

link

Holzlöhner, P., Butze, M., Maier, N., Hebel, N., Schliebs, E., Micheel, B., Füner, J., Heidicke, G., Hanack, K. (2018).

Generation of murine monoclonal antibodies with specificity against conventional camelid IgG1 and heavy-chain only IgG2/3

Veterinary Immunology and Immunopathology, Volume 197, March 2018, Pages 1–6

link


Publikationen 2017

Wittig, BM., Sabat, R., Holzlöhner, P., Witte-Händel, E., Heilmann, K., Witte, K., ... & Günthert, U. (2017).

Absence of specific alternatively spliced exon of CD44 in macrophages prevents colitis.

Mucosal Immunol. Nov 29. doi: 10.1038/mi.2017.98. 

link

Roggenbuck, D., Goihl, A., Hanack, K., Holzlöhner, P., Hentschel, C., Veiczi, M., Schierack, P., Reinhold, D., Schulz, HU. (2017).

Serological diagnosis and prognosis of severe acute pancreatitis by analysis of serum glycoprotein 2.

Clin Chem Lab Med. May 1;55(6):854-864., doi: 10.1515/cclm-2016-0797.

link

Holzlöhner, P., Hanack, K. (2017).

Generation of Murine Monoclonal Antibodies by Hybridoma Technology.

J. Vis. Exp. (119), e54832, doi:10.3791/5483

link


Publikationen 2016

Lütkecosmann, S., Warsinke, A., Tschöpe, W., Eichler, R., & Hanack, K. (2016).

A novel monoclonal antibody suitable for the detection of leukotriene B4.

Biochemical and Biophysical Research Communications.

link

Roggenbuck, D., Goihl, A., Hanack, K., Holzlöhner, P., Hentschel, C., Veiczi, M., Schierack, P., Reinhold, D., Schulz HU. (2016).

Serological diagnosis and prognosis of severe acute pancreatitis by analysis of serum glycoprotein 2.

Clinical Chemistry and Laboratory Medicine (CCLM).

link

Hanack, K., Messerschmidt, K., & Listek, M. (2016).

Antibodies and Selection of Monoclonal Antibodies.

Protein Targeting Compounds (pp. 11-22). Springer International Publishing.

link

Roggenbuck, D., Borghi, M. O., Somma, V., Büttner, T., Schierack, P., Hanack, K., ... & Boccellato, F. (2016).

Antiphospholipid antibodies detected by line immunoassay differentiate among patients with antiphospholipid syndrome, with infections and asymptomatic carriers.

Arthritis research & therapy, 18(1), 1.

link

Schmidt, C., Rödiger, S., Gruner, M., Moncsek, A., Stohwasser, R., Hanack, K., Schierack, P., Schröder, C. (2016).

Multiplex localization of sequential peptide epitopes by use of a planar microbead chip.

Analytica Chimica Acta.

link


Publikationen 2015

Publikationen 2015

Pauly, D., & Hanack, K. (2015).

How to avoid pitfalls in antibody use.

F1000Research.

link

Kaba, H. E., Maier, N., Schliebe-Ohler, N., Mayer, Y., Müller, P. P., van den Heuvel, J., Schuchardt, J., Hanack, K., Bilitewski, U. (2015).

Identification of whole pathogenic cells by monoclonal antibodies generated against a specific peptide from an immunogenic cell wall protein.

Journal of microbiological methods, 108, 61-69.

link